New evidence of anti-IFN-I interference with viral disease outcome should warrant analysis of anti-IFN-Is in individuals with known autoimmune and/or immunodeficiency disorders before giving advice on vaccine modalities for disease prevention and before administrating treatment with IFN-α or -β for certain disorders. The gene discussed is IFNA1; the disease is viral load.